This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo.
Status:
Unknown status
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The current study will investigate the comparative efficacy, safety and patient satisfaction
of intradetrusor injections BOTOX® injections (200U) versus placebo (saline) injections in
the treatment of OAB secondary to benign prostatic obstruction (BPO).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Urological Sciences Research Foundation
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA